Varian Acquires Aspekt Solutions, Strengthening Advanced Oncology Solutions Offering

Acquisition of Aspekt Solutions expands Varian's medical physics and dosimetry services, building on Varian's commitment to providing a holistic approach to cancer care.

Varian, a Siemens Healthineers company, announced today that it has acquired Aspekt Solutions, a leading provider of medical physics, dosimetry, and strategy consultation services. The acquisition of Aspekt Solutions will expand Varian’s Advanced Oncology Solutions (AOS) offerings and increase the ability to address the rising demand for customized services and standardized care delivery.

Cancer care is evolving rapidly, and providers face numerous challenges, including the rising cost of care, technological complexity, and a shortage of skilled personnel. While navigating these challenges, cancer centers strive to meet several competing objectives in clinical quality, operational efficiency, and technology utilization. Through AOS, Varian offers tailored engagements that harness the power of technology and combine it with professional support from world-class experts with diverse clinical and operational experience. These teams collaborate with cancer centers to help them realize their unique goals for expanding, upgrading, or standardizing operations while implementing global best practices in cancer care.

“Through our AOS offerings, we’ve been leading the way in melding innovative technology with clinical expertise to help address these challenges,” commented Chuck Lindley, Vice President of AOS, at Varian. “With Aspekt Solutions, we can support more oncology centers with a holistic approach to addressing today’s challenges while also preparing for the fast-evolving future of cancer care.”

“As part of Varian, we are confident that we will have more opportunities to empower clinicians and patients around the world,” added Brian Pellegrini, CEO of Aspekt Solutions. “We are excited to continue our mission of bringing together the best team of physicists, dosimetrists, and consultants in the industry and partnering with clients to support and extend their existing programs and prepare them for the future. Our immediate focus will be on ensuring that the transition is as smooth as it is beneficial for customers and Aspekt Solutions employees.”

SourceVarian
Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

he Intracept system, a basivertebral nerve ablation therapy, will be an addition to the Boston Scientific chronic pain portfolio that includes spinal cord stimulation, radiofrequency ablation and an interspinous spacer procedure.
"As Probo Medical has grown, we've seen the value of tailoring our commercial offering to the specific needs of specialists that we serve. Davis Medical provides us with exactly that in the cardiology specialty, with decades of experience and a refined approach to support cardiology practices with the equipment, services and supplies they need to run their practice," said Michael Asmer, CEO of Probo. "Additionally, the Davis Medical team adds significant strength to our footprint in the western US."
“This acquisition will provide a much-needed treatment to patients in need,” said Orlaith Ryan, chief technical officer and co-founder of Shorla Oncology. “It brings a crucial oral treatment to a larger patient population who suffer from cancer and other debilitating illnesses.”
Paragon Medical serves a wide range of specialty applications including orthopedics, minimally invasive surgery, robotic surgery, and drug delivery. Paragon's product portfolio includes single-use and consumable surgical instruments and implantable components sold to a diverse blue-chip customer base of leading medical device manufacturers.
“Time is of the essence during medical emergencies, as we saw in 2022 when EU member states required emergency shipments of Tecovirimat SIGA to treat patients infected with mpox,” said Meridian Medical Technologgies Commercial Head – Injectables & Health Security, Tom Handel. “This joint procurement framework contract, a significant milestone for both Meridian and HERA, reduces the time and effort required to put individual contracts in place with each member state from months to days. There are now multiple paths in Europe for streamlined procurement, allowing member state agencies to get much needed medical countermeasures into the hands of those in need.”

By using this website you agree to accept Medical Device News Magazine Privacy Policy